PL2037902T3 - Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego - Google Patents
Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznegoInfo
- Publication number
- PL2037902T3 PL2037902T3 PL07733311T PL07733311T PL2037902T3 PL 2037902 T3 PL2037902 T3 PL 2037902T3 PL 07733311 T PL07733311 T PL 07733311T PL 07733311 T PL07733311 T PL 07733311T PL 2037902 T3 PL2037902 T3 PL 2037902T3
- Authority
- PL
- Poland
- Prior art keywords
- cannabinoids
- treatment
- neuropathic pain
- neuropathic
- pain
- Prior art date
Links
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 229940065144 cannabinoids Drugs 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 title 1
- 208000021722 neuropathic pain Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0612512A GB2439393B (en) | 2006-06-23 | 2006-06-23 | Cannabinoids for use in the treatment of neuropathic pain |
EP07733311.0A EP2037902B1 (en) | 2006-06-23 | 2007-06-21 | Cannabinoids for use in the treatment of neuropathic pain |
PCT/GB2007/002315 WO2007148094A1 (en) | 2006-06-23 | 2007-06-21 | Cannabinoids for use in the treatment of neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2037902T3 true PL2037902T3 (pl) | 2013-12-31 |
Family
ID=36803806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07733311T PL2037902T3 (pl) | 2006-06-23 | 2007-06-21 | Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego |
Country Status (8)
Country | Link |
---|---|
US (3) | US20100016418A1 (pl) |
EP (1) | EP2037902B1 (pl) |
JP (2) | JP5399898B2 (pl) |
CA (1) | CA2656698C (pl) |
ES (1) | ES2429406T3 (pl) |
GB (1) | GB2439393B (pl) |
PL (1) | PL2037902T3 (pl) |
WO (1) | WO2007148094A1 (pl) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
GB2439393B (en) * | 2006-06-23 | 2011-05-11 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
GB2450753B (en) * | 2007-07-06 | 2012-07-18 | Gw Pharma Ltd | New Pharmaceutical formulation |
EP2176208B1 (en) | 2007-07-30 | 2015-01-21 | Zynerba Pharmaceuticals, Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
GB2456183A (en) * | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
GB2471523A (en) * | 2009-07-03 | 2011-01-05 | Gw Pharma Ltd | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
US8445034B1 (en) | 2010-11-02 | 2013-05-21 | Albert L Coles, Jr. | Systems and methods for producing organic cannabis tincture |
GB2524689B (en) * | 2011-05-20 | 2016-01-27 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
EP2934512B1 (en) | 2012-12-18 | 2021-11-24 | Kotzker Consulting LLC | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
GB2524469A (en) * | 2014-02-14 | 2015-09-30 | Kind Consumer Ltd | A cannabinoid inhaler and composition therefor |
US9918961B2 (en) | 2014-02-19 | 2018-03-20 | Kind Consumer Limited | Cannabinoid inhaler and composition therefor |
CA2944837C (en) * | 2014-04-21 | 2021-10-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Cyclohexenyl compounds, compositions comprising them and uses thereof |
US10610512B2 (en) | 2014-06-26 | 2020-04-07 | Island Breeze Systems Ca, Llc | MDI related products and methods of use |
US9844518B2 (en) | 2014-09-30 | 2017-12-19 | MJAR Holdings, LLC | Methods of growing cannabaceae plants using artificial lighting |
US20180289665A1 (en) * | 2014-12-07 | 2018-10-11 | One World Cannabis Ltd | Use of cannabis to treat migraine |
US20160298151A1 (en) | 2015-04-09 | 2016-10-13 | Sher Ali Butt | Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products |
WO2016189384A1 (en) | 2015-05-28 | 2016-12-01 | Tweed Inc. | Cannabis plants having modified expression of thca synthase |
MX2018006381A (es) * | 2015-11-24 | 2019-02-14 | Constance Therapeutics Inc | Composiciones de aceite de cannabis y metodos para preparacion de las mismas. |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
JP2019524655A (ja) | 2016-06-29 | 2019-09-05 | キャンサイエンス イノベーションズ インコーポレーテッドCannscience Innovations Inc. | 脱炭酸大麻樹脂、その使用、及びそれを製造する方法 |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
CA3074173A1 (en) * | 2017-09-01 | 2019-03-07 | Pureform Global, Inc. | Synthetic cannabidiol compositions and methods of making the same |
EP3681525A4 (en) * | 2017-09-15 | 2020-09-02 | Zelda Therapeutics Operations Pty Ltd | COMPOSITION AND METHOD OF PROCESSING AUTISM |
US20200289458A1 (en) * | 2017-09-22 | 2020-09-17 | Inmed Pharmaceuticals Inc. | Topical formulations of cannabinoids and use thereof in the treatment of pain |
US20190183849A1 (en) * | 2017-10-21 | 2019-06-20 | Alexander Kariman | Compound and method for treatment of diseases and disorders |
US20200315933A1 (en) * | 2017-12-20 | 2020-10-08 | Hanyi Bio-Technology Company Ltd. | Use of cannabidiol or cannabis extract in preparation of skin whitening products |
WO2019152736A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
GB201806953D0 (en) * | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
SI25373A (sl) * | 2018-05-08 | 2018-08-31 | Danijela Marković | Naravna orodisperzibilna tableta |
CN112672740A (zh) * | 2018-06-15 | 2021-04-16 | 康宝动物治疗有限公司 | 大麻素组合物以及使用大麻素组合物的治疗方法 |
AU2019335372A1 (en) * | 2018-09-05 | 2021-05-06 | Purisys Llc | Cannabidiol compositions having modified cannabinoid profiles |
CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
WO2020220092A1 (en) * | 2019-05-01 | 2020-11-05 | Cannadol Pharmaceuticals | Compositions and methods for pain and anxiety relief |
US20210401794A1 (en) * | 2020-06-30 | 2021-12-30 | Np Pharma Holdings, Llc | Methods of Using Cannabinoid Compositions for Inducing and Promoting Sleep |
US11478446B2 (en) | 2020-08-28 | 2022-10-25 | Teresa Ann HANLON | Pain relieving formulations containing cannabis and methods of making same |
WO2022159507A1 (en) * | 2021-01-19 | 2022-07-28 | Merit Therapeutics, Inc. | Combination of cannabinoids with additional therapeutic agents for treating diseases or disorders |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
SI1361864T1 (sl) * | 2001-02-14 | 2014-04-30 | Gw Pharma Limited | Kapljevite pršilne formulacije za bukalno administracijo kanabinoidov |
CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
GB2381450B (en) * | 2001-10-31 | 2006-05-31 | Gw Pharma Ltd | Compositions for administration of natural or synthetic cannabinoids by vaporisation |
GB2391865B (en) * | 2002-08-14 | 2005-06-01 | Gw Pharma Ltd | Improvements in the extraction of pharmaceutically active components from plant materials |
ATE533472T1 (de) * | 2002-08-14 | 2011-12-15 | Gw Pharma Ltd | Flüssige cannabinoid-formulierungen zur verabreichung an die schleimhäute |
GB2394894B (en) * | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
GB2414933B (en) * | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
GB2439393B (en) * | 2006-06-23 | 2011-05-11 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
-
2006
- 2006-06-23 GB GB0612512A patent/GB2439393B/en not_active Expired - Fee Related
-
2007
- 2007-06-21 CA CA2656698A patent/CA2656698C/en active Active
- 2007-06-21 WO PCT/GB2007/002315 patent/WO2007148094A1/en active Application Filing
- 2007-06-21 JP JP2009517376A patent/JP5399898B2/ja active Active
- 2007-06-21 US US12/308,776 patent/US20100016418A1/en not_active Abandoned
- 2007-06-21 EP EP07733311.0A patent/EP2037902B1/en active Active
- 2007-06-21 ES ES07733311T patent/ES2429406T3/es active Active
- 2007-06-21 PL PL07733311T patent/PL2037902T3/pl unknown
-
2012
- 2012-06-07 US US13/491,077 patent/US20120245224A1/en not_active Abandoned
-
2013
- 2013-09-03 JP JP2013182318A patent/JP2013241471A/ja active Pending
-
2018
- 2018-09-26 US US16/142,394 patent/US20190224140A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2037902A1 (en) | 2009-03-25 |
CA2656698A1 (en) | 2007-12-27 |
JP2013241471A (ja) | 2013-12-05 |
EP2037902B1 (en) | 2013-07-03 |
US20190224140A1 (en) | 2019-07-25 |
GB2439393A (en) | 2007-12-27 |
CA2656698C (en) | 2015-10-13 |
US20120245224A1 (en) | 2012-09-27 |
JP2009541479A (ja) | 2009-11-26 |
US20100016418A1 (en) | 2010-01-21 |
JP5399898B2 (ja) | 2014-01-29 |
WO2007148094A1 (en) | 2007-12-27 |
ES2429406T3 (es) | 2013-11-14 |
GB2439393B (en) | 2011-05-11 |
GB0612512D0 (en) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2439393B (en) | Cannabinoids for use in the treatment of neuropathic pain | |
GB0610867D0 (en) | Treatment of pain | |
PL1978947T3 (pl) | Nitrooksypochodne do zastosowania w leczeniu dystrofii mięśniowych | |
IL198663A0 (en) | Tissue treatment methods | |
EP1982660A4 (en) | TREATMENT ENDOSCOPE | |
IL193748A0 (en) | Treatment of pain | |
IL185485A0 (en) | Use of pde7 inhibitors for the treatment of neuropathic pain | |
GB0602178D0 (en) | Therapeutic treatment | |
IL194202A0 (en) | Treatment using citrulline | |
HUE037109T2 (hu) | Endoxifén rák kezelésében történõ alkalmazásra | |
GB0608655D0 (en) | Therapeutic Treatment | |
ZA200806808B (en) | Treatment of stressed patients | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
GB0822486D0 (en) | Compounds for use in the treatment of pain | |
EP2007790A4 (en) | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | |
GB0624936D0 (en) | Fluid treatment | |
GB0610909D0 (en) | Therapeutic treatment | |
IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
GB0610868D0 (en) | Treatment of pain | |
ZA200707147B (en) | Use of PDE7 inhibitors for the treatment of neuropathic pain | |
GB0604460D0 (en) | Treatment | |
GB0616450D0 (en) | Treatment of pain | |
ZA200807154B (en) | Liquid treatment composition | |
GB2444056B (en) | Liquid treatment system | |
GB0602857D0 (en) | The treatment of sialorrhoea |